International Patent: NOVEL SUBSTITUTED HETEROCYCLIC COMPOUND AS STATS-TARGETING DEGRADATION AGENT

GENEVA, Sept. 24 -- HANGZHOU GLUELINKER BIO THERAPEUTICS CO., LTD filed a patent application (CN2026/084431) for “NOVEL SUBSTITUTED HETEROCYCLIC COMPOUND AS STATS-TARGETING DEGRADATION AGENT”. With publication no. WO/2026/194970, here are the other details related to the patent application:

Kind: Initial Publication with ISR [A1]

IPC: C07D 403/14

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....